MEDICAL IP, AI-based preventive medicine agreement with Seoul National University Hospital Gangnam Center
MEDICAL IP, supply AI solution to Seoul National University Hospital Gangnam Center and start joint research
▶Signed MOU to jointly conduct CT analysis research and validation using DeepCatch
▶ Developing a 'disease prediction model'
by analyzing tens of thousands of cohort CT data with AI technology
<2021-04-08> MEDICALIP accelerates the development of disease prevention medical solutions through artificial intelligence technology. MEDICALIP signed a business agreement with Seoul National University Hospital Gangnam Center to conduct artificial intelligence analysis and joint research on CT images.
After this agreement, the two organizations will begin joint research, such as CT analysis and research using artificial intelligence technology based on medical image big data.
MEDICALIP's automatic body composition analysis AI software, DeepCatch, will be used to analyze tens of thousands of cohort data held by Seoul National University Hospital Gangnam Center. Based on this, the body composition standard values and disease occurrence prediction criteria will be established.
The goal is to come up with a solution that can predict and prevent various diseases that accompany changes in body composition in advance by combining the medical big data owned by Seoul National University Hospital Gangnam Center and the AI medical image analysis technology developed by MEDICALIP.